Lactobacillus casei inhibits antigen-induced IgE secretion through regulation of cytokine production in murine splenocyte cultures

International Archives of Allergy and Immunology

Volumn 115, Issue 4, 1998, Pages 278-287

  Shida, Kan ^a,b   Makino, Kumiko ^b   Morishita, Aki ^b   Takamizawa, Kotaro ^b   Hachimura, Satoshi ^a   Ametani, Akio ^a   Sato, Takehito ^c   Kumagai, Yoshihiro ^d   Habu, Sonoko ^c   Kaminogawa, Shuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^c TOKAI UNIVERSITY   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Cytokines; IFN ; IgE; IL 12; Lactic acid bacteria; Lactobacillus casei; Th1 Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; FEMALE; HELPER CELL; IMMUNOSTIMULATION; LACTOBACILLUS CASEI; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TRANSGENIC MOUSE;

ALLERGENS; ANIMALS; CELL LINE; CYTOKINES; FEMALE; IMMUNOGLOBULIN E; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-4; INTERLEUKIN-5; LACTOBACILLUS CASEI; MACROPHAGES; MICE; MICE, INBRED BALB C; OVALBUMIN; SPLEEN;

EID: 6844255210     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069458     Document Type: Article

References (32)

1. Coffman RL, Ohara J, Bond MW, Carty J, Zlontnik A, Paul WE: B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol 1986;136: 4538-4541.
2. Pen J, Rousset F, Briere F, Chretien I, Wideman J, Bonnefoy JY, De Vries JH: Inlerleukin 5 enhances interleukin 4-induced IgE production by normal human B cell. The role of soluble CD23. Eur J Immunol 1988;18:929-935.
3. Maggi E, Der Prete GF, Parronchi P, Tiri A, Macchia D, Biswas P, Simonelli C, Ricci M, Romagnani S: Role for T cells, IL-2 and IL-6 in the IL-4 dependent in vitro human IgE synthesis. Immunology 1989;68:300-306.
4. Thyphronitis G, Tsokos GC, June CH, Levine AD, Finkelman FD: IgE secretion by Epstein-Bar virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon γ. Proc Natl Acad Sci USA 1989;86:5580-5584.
5. Gajewski TF, Fitch FW: Anti-proliferative effect of IFN-γ in immune regulation. I. IFN-γ inhibits the proliferation of Th2 but not Th1 murinc helper T lymphocyte clones. J Immunol 1988;140:4245-4252.
6. Powrie F, Coffman RL: Cytokine regulation of T-cell function: Potential for therapeutic intervention. Immunol Today 1993;14:270-274.
7. Gilliland SE: Acidophilus milk products: A review of potential benefits to consumers. J Dairy Sci 1989;72:2483-2494.
8. Fernandes CF, Shahani KM: Anticarcinogenic and immunological properties of dietary lactobacilli. J Food Protect 1990;53:704-710.
9. Kato I, Kobayashi S, YokokuraT, Mutai M: Antitumor activity of Lactobacillus casei in mice. Gann 1981;72:517-523.
10. Matsuzaki T, Yokokura T, Mutai M: Antitumor effect of intrapleural administration of Lactobacillus casei in mice. Cancer Immunol Immunother 1988;26:209-214.
11. Miake S, Nomoto K, Yokokura T, Yoshikai Y, Mutai M, Nomoto K: Protective effect of Lactobacillus casei on Pseudomonas aeruginosa infection in mice. Infect Immun 1985;48:480-485.
12. Nomoto K, Miake S, Hashimoto S, Yokokura T, Mutai M, Yoshikai Y, Nomoto K: Augmentation of host resistance to Listeria monocytogenes infection by Lactobacillus casei. J Clin Lab Immunol 1985;17:91-97.
13. Kato I, Yokokura T, Mutai M: Macrophage activation by Lactobacillus casei in mice. Microbiol Immunol 1983;27:611-618.
14. Kato I, Yokokura T, Mutai M: Augmentation of mouse natural killer cell activity by Lactobacillus casei and its surface antigens. Microbiol Immunol 1984;27:209-217.
15. Kato I, Yokokura T, Mutai M: Correlation between increase in la-bearing macrophages and induction of T-cell-dependent antitumor activity by Lactobacillus casei in mice. Cancer Immunol Immunother 1988;26:215-221.
16. De Simone C, Salvadori BB, Negri R, Ferrazzi M, Baldinelli L, Vesely R: The adjuvant effect of yogurt on production of gamma-interferon by Con A-stimulated human peripheral blood lymphocytes. Nutr Rep Int 1986;33:419-433.
17. Sato T, Sasahara T, Nakamura Y, Osaki T, Hasegawa T, Tadakura T, Arata Y, Kumagai Y , Katsuki M, Habu S: Naive T cells can mediate delayed-type hypertensitivity response in T cell receptor transgenic mice. Fur J Immunol 1994; 24:1512-1516.
18. Marcelletti JF, Katz DH: Elicitation of antigen-induced primary and secondary murine IgE antibody responses in vitro. Cell Immunol 1991; 135:471-489.
19. Hsieh C-S, Macatonia SE, O'Garra A, Murphy KM: Pathogen-induced ThI phenotype development in CD4+ αβ-TCR transgenic T cells is macrophage dependent. Int Immunol 1993;5: 371-382.
20. Germann T, Rüde E: Interleukin-12. Int Arch Allergy Immunol 1995;108:103-112.
21. Trinchieri G: Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84:4008-4027.
22. Hsieh C-S, Heimberger AB, Golg JS, O'Garra A, Murphy KM: Differential regulation of T helper phenotype development by interleukins 4 and 10 in an αβT-cell-receptor transgenic system. Proc Natl Acad Sci USA 1992;89:6065-6060.
23. Hsieh C-S, Macatonia SE, Tripp CS, Wolf SF, O'Garra A, Murphy KM: Development of Th1 CD4+ T cells through IL-12 produced by Listeriu-induced macrophages. Science 1993;260: 547-549.
24. Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G: Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest 1992;90:262-266.
25. Morris SC, Madden KB, Adamovicz JJ, Gause WC, Hubbard BR, Gately MK, Finkelman FD: Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 1994;152:1047-1056.
26. Gavett SH, O'Hearn DJ, Li X, Huang S-K, Finkelman FD, Wills-Karp M: Interleukin 12 inhibits antigen-induced airway hyperresponsiveness. inflammation, and Th2 cytokine expression in mice. J Exp Med 1995;182:1527-1536.
27. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK: Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 1993;178:1223-1230.
28. Tripp CS, Gately MK, Hakimi J, Ling P, Unanue ER: Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. J Immunol 1994;152:1883-1887.
29. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix C, Wolf S, Shearer G: Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993;262:1721-1724.
30. Kubin M, Chow JM, Trinchieri G: Differential regulation of interleukin-12 (IL-12), tumor necrosis factor α, and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 1994;83:1847-1855.
31. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM: Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996;64:1906-1912.
32. Kato I, Endo K, Yokokura T: Effect of oral administration of Lactohacillus casei on antitumor responses induced by tumor resection in mice. Int J Immunopharmacol 1994;16:29-36.